Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Generic
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ZTS | Zoetis, Inc. | 0.91% | 139.37 | 1.9% | $325.68m | |
| TEVA | Teva Pharmaceutical Industries Ltd. | -3.02% | 12.53 | 2.0% | $167.10m | |
| MYL | Mylan NV | -1.04% | 17.07 | 3.2% | $119.63m | |
| BBIO | BridgeBio Pharma, Inc. | -16.46% | 29.33 | 0.0% | $16.53m | |
| RDY | Dr. Reddy's Laboratories Ltd. | 3.97% | 53.46 | 2.0% | $12.52m | |
| TXMD | TherapeuticsMD, Inc. | -3.42% | 1.13 | 22.1% | $6.40m | |
| ABEO | Abeona Therapeutics, Inc. | 2.16% | 3.31 | 4.5% | $3.87m | |
| TARO | Taro Pharmaceutical Industries Ltd. | -1.46% | 68.06 | 6.5% | $2.13m | |
| COCP | Cocrystal Pharma, Inc. | 0.08% | 0.97 | 0.0% | $1.80m | |
| JAGX | Jaguar Health, Inc. | 14.29% | 0.48 | 2.0% | $1.65m | |
| LFVN | LifeVantage Corp. | 0.92% | 15.31 | 3.3% | $1.58m | |
| KIN | Kindred Biosciences, Inc. | -2.50% | 4.29 | 0.3% | $1.46m | |
| CPHI | China Pharma Holdings, Inc. | -3.80% | 0.45 | 0.1% | $0.55m |
Company Profile
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.